TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 7 | -3 | -4 | -4 | -6 | -9 | 13 | -2 |
| S | %wins | 100 | 86 | 57 | 71 | 71 | 57 | 74 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/5/17 17:17 | 12/4/17 | INVA | Innoviva, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Aguiar Michael W | CA | DO | P,Chief | S | -158 | 13.13 | 0 | -12 | -1 | 981 | D | ||||||||||||||
5/2/13 19:04 | 4/30/13 | THRX | Theravance Inc | DE | Health | Drug | Pharmaceutical Preparations | Aguiar Michael W | CA | O | SVP,CFO | S.d | -5,776 | 33.80 | 33 | -171 | -55 | 142 | D | 17 | 55 | 31 | 52 | 43 | 44 | 4 | -1 | -1 | -8 | 2 | 13 | 10 | -22 |
8/28/12 19:01 | 8/24/12 | THRX | Theravance Inc | DE | Health | Drug | Pharmaceutical Preparations | Aguiar Michael W | CA | O | SVP,CFO | S.dm | -677 | 27.44 | 15 | -25 | -16 | 132 | D | 110 | 47 | 46 | 18 | -12 | -1 | 0 | 0 | -1 | -5 | -7 | -22 | -23 | 34 |
8/9/12 19:00 | 8/7/12 | THRX | Theravance Inc | DE | Health | Drug | Pharmaceutical Preparations | Aguiar Michael W | CA | O | SVP,CFO | S.d | -1,622 | 27.04 | 27 | -60 | -28 | 158 | D | 60 | 38 | 48 | 25 | 23 | -11 | -11 | -4 | -1 | 2 | -8 | -22 | -17 | 39 |
5/31/12 19:27 | 5/29/12 | THRX | Theravance Inc | DE | Health | Drug | Pharmaceutical Preparations | Aguiar Michael W | CA | O | SVP,CFO | S | -446 | 22.29 | 12 | -20 | -11 | 158 | D | 59 | -20 | 0 | 12 | 3 | -1 | 3 | -4 | -9 | -8 | 3 | 31 | 3 | 71 |
12/13/11 19:02 | 12/9/11 | THRX | Theravance Inc | DE | Health | Drug | Pharmaceutical Preparations | Aguiar Michael W | CA | O | SVP,CFO | S | -219 | 21.86 | 11 | -10 | -5 | 187 | D | 78 | -13 | 1 | 17 | 5 | 8 | -3 | 2 | -4 | -6 | -22 | -19 | -21 | -2 |
6/16/11 19:00 | 6/14/11 | THRX | Theravance Inc | DE | Health | Drug | Pharmaceutical Preparations | Aguiar Michael W | CA | O | SVP,CFO | S | -326 | 22.94 | 14 | -14 | -7 | 202 | D | 66 | 48 | -18 | 5 | -9 | -8 | -2 | 1 | -7 | -3 | 6 | -10 | 0 | -18 |
12/3/10 19:16 | 12/3/10 | THRX | Theravance Inc | DE | Health | Drug | Pharmaceutical Preparations | Aguiar Michael W | CA | O | SVP,CFO | S | -265 | 26.51 | 12 | -10 | -8 | 110 | D | 273 | 83 | 80 | 99 | 19 | 25 | 18 | 3 | -1 | 0 | -3 | -14 | -13 | -10 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |